Johnson & Johnson Private Limited
Clinical trials sponsored by Johnson & Johnson Private Limited, explained in plain language.
-
New hope for indian patients with Hard-to-Treat blood cancer
Disease control Recruiting nowThis study is checking the safety of a drug called teclistamab for Indian patients with advanced multiple myeloma, a type of blood cancer that has returned or stopped responding to previous treatments. It will include about 75 adults whose cancer has worsened despite trying at le…
Phase: PHASE4 • Sponsor: Johnson & Johnson Private Limited • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New hope for indian patients with stubborn arthritis
Disease control Recruiting nowThis study is testing how safe and effective the drug guselkumab is for Indian patients with psoriatic arthritis, a painful autoimmune condition that affects the joints and skin. It is for people whose symptoms have not improved enough with standard medications. Researchers will …
Phase: PHASE4 • Sponsor: Johnson & Johnson Private Limited • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC